Yao et al., 2023)
If morning dosing does not work with your schedule, evening dosing is an acceptable alternative
In cases of chronic disease, higher dosages can be recommended by a healthcare professional
Availability will depend on supply and commissioning decisions, and it may still take some time for the medication to become available on the NHS
While SURPASS-4 was not powered to evaluate differences in MACE-4 incidence between tirzepatide treatment groups and glargine, it was designed to fulfill the MACE-4 non-inferiority analysis requested by regulatory authorities to evaluate the cardiovascular safety of new glucose lowering medications
White WB, Cannon CP, Heller SR, Nissen SE, Bergenstal RM, Bakris GL, et al